Literature DB >> 3011348

Abnormal B-cell response to T-cell-independent polyclonal B-cell activators in homosexuals presenting persistent generalized lymph node enlargement and HTLV-III antibodies.

J Kekow, P Kern, H Schmitz, W L Gross.   

Abstract

B-cell functions were investigated in a well-defined high-risk group for the development of AIDS/AIDS-related complex (ARC). Stimulation of mononuclear cells (MNC) with T-cell-independent polyclonal B-cell activators failed to increase high spontaneous IgG levels observed in vivo and in vitro. The secretion of IgM following stimulation with Klebsiella M (Klebs M) or Salmonella (Salm) membrane preparation increased by a factor of 4 to 6 and thus ranged between the results of the control group and those of AIDS/ARC patients; the response to a T-cell-independent B-cell mitogen, Staphylococcus aureus Cowan I (SAC), showed profound abnormalities as well in this group. This indicates that functional B-cell abnormalities can be seen in addition to T-cell dysfunctions in patients at increased risk for the development of AIDS/ARC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011348

Source DB:  PubMed          Journal:  Diagn Immunol        ISSN: 0735-3111


  4 in total

1.  Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia.

Authors:  M Medina-Ramírez; V Sánchez-Merino; S Sánchez-Palomino; A Merino-Mansilla; C B Ferreira; I Pérez; N González; A Alvarez; J M Alcocer-González; F García; J M Gatell; J Alcamí; E Yuste
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

2.  Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.

Authors:  F Vuillier; D Scott-Algara; P Tortevoye; G Pialoux; G Dighiero
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

Review 3.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

4.  Transforming growth factor-beta and suppression of humoral immune responses in HIV infection.

Authors:  J Kekow; W Wachsman; J A McCutchan; W L Gross; M Zachariah; D A Carson; M Lotz
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.